603520.SS · 司太立
China A-shares · RS rating 30 · As of 2026-10-14
| Price | 8.28 CNY |
|---|---|
| 1-day change | -1.7% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 52 / 30 / 31 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 19 / 17 / 12 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -1.2% |
| Distance from 52-week high | +39.8% |
| Market cap (USD) | $560.6M |